Phenibut, tablets 250 mg 20 pcs

Phenibut is a nootropic medicine.

Removes tension, anxiety and fear, improves sleep. It prolongs the latent period and shortens the duration and severity of nystagmus, has an antiepileptic effect.

Limits manifestations of asthenia and vasovetegetative symptoms, including headache, feeling of heaviness in the head, sleep disturbance, irritability, emotional lability, increases mental performance. Improves psychological parameters: attention, memory, speed and accuracy of sensory-motor reactions.

Patients from the first days of therapy feel better, interest and initiative, motivation of activity are increased.
Phenibut administration after severe traumatic brain injury increases the number of mitochondria in perifocal areas and improves bioenergetic processes in the brain.

Phenibut also has an antioxidant effect.

When used in the elderly, Phenibut does not cause congestion and excessive lethargy.
It normalizes the processes of lipid peroxidation. Does not affect the choline and adrenoreceptors.

Indications

Asthenic and anxious-neurotic states, anxiety, fear, obsessive-compulsive neurosis, psychopathy.
Stuttering and tics in children, enuresis.
Urinary retention due to myelodysplasia.
Insomnia and nightmares in the elderly.
Prevention of anxiety states that arise before surgical interventions and painful diagnostic tests (premedication).
Meniere’s disease, dizziness associated with dysfunctions of the vestibular analyzer of various origins (including otogenic labyrinthitis, vascular and traumatic disorders); prevention of motion sickness during kinetosis.
Primary open-angle glaucoma (as part of combination therapy).
As an auxiliary therapy in the treatment of alcoholism (for the relief of psychopathological and somatovegetative disorders during withdrawal syndrome).
Treatment of predelirious and delirious states in alcoholism (in combination with conventional detoxification agents).

Pharmacological effect

Phenibut is a nootropic drug.

Eliminates tension, anxiety and fear, improves sleep. Extends the latent period and shortens the duration and severity of nystagmus, has an antiepileptic effect.

Reduces manifestations of asthenia and vasovegetative symptoms, incl. headache, feeling of heaviness in the head, sleep disturbance, irritability, emotional lability, increases mental performance. Improves psychological indicators: attention, memory, speed and accuracy of sensory-motor reactions.

From the first days of therapy, patients experience improved well-being, increased interest, initiative, and motivation for activity.
When using Phenibut after severe traumatic brain injury, the number of mitochondria in the perifocal areas increases and the course of bioenergetic processes in the brain improves.

Phenibut also has an antioxidant effect.

When used in elderly people, Phenibut does not cause congestion and excessive lethargy.
Normalizes lipid peroxidation processes. Does not affect cholinergic and adrenergic receptors.

Special instructions

The drug is prescribed with caution for erosive and ulcerative lesions of the gastrointestinal tract.

With long-term use, it is necessary to monitor liver function indicators and peripheral blood patterns.

Impact on the ability to drive vehicles and operate machinery

It is necessary to refrain from engaging in potentially hazardous activities that require increased attention.

Active ingredient

Aminophenylbutyric acid

Composition

1 tablet contains:

active substance:

γ-amino-β-phenylbutyric acid hydrochloride 250 mg

Contraindications

individual intolerance to Phenibut;
pregnancy;
breastfeeding period;
liver failure.

Side Effects

From the side of the central nervous system: increased irritability, agitation, anxiety, dizziness, headache, drowsiness.

From the digestive system: nausea (at the first doses).

Allergic reactions: skin rash, itching.

Interaction

When used together, Phenibut prolongs and enhances the effect of hypnotics, antipsychotics, anticonvulsants, and opioid analgesics.

Overdose

Symptoms: drowsiness, nausea, vomiting, arterial hypotension, renal failure. With long-term use of Phenibut in a daily dose of 7-14 g, the development of hepatotoxicity (including fatty liver degeneration) and eosinophilia is possible.

Treatment: gastric lavage, symptomatic and supportive therapy.

Storage conditions

Store in a dry place, protected from light, out of reach of children at temperatures up to 25°C.

Shelf life

3 years.

Manufacturer

Ozon, Russia